Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Cancer Research|November 17, 2007
Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in miceHanchen Li, Xueli Fan, Ramesh C Kovi, et al.Cancer|January 30, 2002
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinomaDavid P Ryan, Matthew H Kulke, Charles S Fuchs, et al.Journal of Clinical Pathology|May 26, 2010
Comparison of histopathology and RT-qPCR amplification of guanylyl cyclase C for detection of colon cancer metastases in lymph nodesJean-François Haince, Michel Houde, Guillaume Beaudry, et al.Nature Communications|January 30, 2021
The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3Catherine A Vaughan, Shilpa Singh, Mark A Subler, et al.Bioorganic & Medicinal Chemistry|May 9, 2016
Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP)Sudha Korwar, Benjamin L Morris, Hardik I Parikh, et al.Scientific Reports|December 6, 2025
Combined inhibition of NAD synthesis and C-terminal binding protein cooperatively induces cell death and inhibits growth of high grade serous ovarian carcinomaKranthi Kumar Chougoni, Jacqueline West, Nicholette St Martin, et al.Gastrointestinal Cancer Research : GCR|December 7, 2013
A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic AdenocarcinomaVolkan Cetin, Bilal Piperdi, Venu Bathini, et al.Molecular and Cellular Biology|July 19, 2005
ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylationRemy Pedeux, Sagar Sengupta, Jiang Cheng Shen, et al.Oncogenesis|October 6, 2019
CtBP-a targetable dependency for tumor-initiating cell activity and metastasis in pancreatic adenocarcinomaAyesha T Chawla, Kranthi Kumar Chougoni, Prashant J Joshi, et al.Cancer Research Communications|September 20, 2024
Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial ApoptosisKranthi Kumar Chougoni, Victoria Neely, Boxiao Ding, et al.Pageof 7